Revolution Medicines Inc.

NASDAQ: RVMD · Real-Time Price · USD
36.30
0.28 (0.78%)
At close: Aug 15, 2025, 3:59 PM
36.32
0.04%
After-hours: Aug 15, 2025, 04:34 PM EDT

Revolution Medicines Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-812.06M -697.51M -600.09M -567.06M -519.21M -484.27M -436.37M -331.34M -296.23M -259.16M -248.71M -244.87M -224.49M -207.56M -187.09M -168.62M -142.9M -125.82M
Depreciation & Amortization
-13.57M 9.97M 9.01M 8.48M 10.56M 9.54M 9.31M 9.05M 9.34M 9.9M 9.66M 9.12M 8.44M 7.94M 7.33M 6.97M 6.85M 6.68M
Stock-Based Compensation
97.13M 88.07M 79.2M 82.19M 75.08M 68.28M 61.77M 44.66M 39.13M 34.25M 31.2M 29.08M 26.77M 23.98M 20.72M 17.16M 14M 10.71M
Other Working Capital
28.57M 38.62M 8.4M 4.53M -15.25M -16.02M 907K -20.24M -15.09M -17.42M -22.01M -13.05M -7.96M -6.34M -1.66M -180K -7.7M -4.25M
Other Non-Cash Items
-11.54M -44.69M 693K 3.79M 10.62M 18.53M -18.17M -11.88M 63K 4.94M 9.18M 12.26M 2.6M 3.26M 3.13M 2.45M 1.85M 1.25M
Deferred Income Tax
-762K -762K -762K -43K -3.91M -3.91M -3.91M -4.29M -419K -419K -419K n/a n/a n/a n/a 359K 359K 359K
Change in Working Capital
55.15M 52.84M 3.19M -17.63M -33.48M -7.47M 36.8M 1.99M 16.9M -9.32M -13.49M 4.36M -45K 7.28M 8.72M 8.73M -3.55M -2.47M
Operating Cash Flow
-684.9M -591.31M -557.44M -539.71M -509.79M -448.74M -350.57M -291.8M -243.04M -231.63M -224.4M -201.88M -186.73M -165.09M -147.18M -132.95M -123.38M -109.29M
Capital Expenditures
-15.46M -10.41M -10.31M -11.4M -10.42M -9.14M -7.73M -8.29M -9.28M -10.69M -10.82M -9.12M -6.05M -4.84M -6.53M -6.51M -6.75M -5.91M
Cash Acquisitions
n/a n/a n/a 884.05M 804.16M 846.59M 840.83M -38.99M 40.9M -66.45M -60.7M -64.93M -64.93M n/a n/a n/a n/a n/a
Purchase of Investments
-2.1B -1.94B -2.14B -1.96B -1.77B -1.57B -1.06B -699.65M -742.57M -694.05M -612.77M -563.25M -518.53M -669.12M -671.34M -605.4M -631.2M -558.13M
Sales Maturities Of Investments
1.72B 1.63B 1.59B 1.43B 1.33B 982.08M 724.05M 738.63M 581.76M 640.59M 599.47M 563.89M 609.37M 573.55M 535.75M 524.21M 479.45M 391.83M
Other Investing Acitivies
n/a 110.34M -134.46M -1.02B -938.62M -1.09B -840.83M 38.99M -160.81M -53.46M -13.3M 644K 90.83M -95.56M -135.59M -81.19M -151.75M -166.3M
Investing Cash Flow
-396.05M -322.38M -554.39M -541.89M -443.07M -594.56M -342.6M 30.7M -170.09M -64.14M -24.12M -8.48M 84.78M -100.4M -142.12M -87.7M -158.49M -172.21M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
6.51M 5.03M 5.03M 6.48M 6.48M 3.32M 3.32M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -5K
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
354.74M 113.13M 113.06M 850.67M 848.68M 843.75M 843.44M 5.53M 4.73M 3.58M 3.39M 2.58M 2.69M 2.12M 2.37M 3.23M 3.98M 3.2M
Financial Cash Flow
1.21B 959.48M 959.41M 924.96M 848.68M 905.8M 1.23B 441.21M 688.53M 625.33M 301.43M 260.8M 12.78M 12.22M 294.18M 284.94M 453.5M 451.3M
Net Cash Flow
127.61M 45.79M -152.42M -157.28M -104.82M -138.14M 535.39M 180.11M 275.41M 329.56M 52.91M 50.44M -89.17M -253.28M 4.88M 64.28M 171.62M 169.8M
Free Cash Flow
-700.36M -601.72M -567.74M -551.11M -520.21M -457.88M -358.3M -300.08M -252.31M -242.32M -235.22M -211M -192.78M -169.93M -153.71M -139.46M -130.13M -115.2M